Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
Risk Factors for Melanoma in Non-Hodgkin Lymphoma Identified! The study suggests that people with non-Hodgkin Lymphoma should be monitored carefully in order to detect signs of melanoma earlier, when it is potentially more treatable. Read more! http://bit.ly/1JUDQpu ... Read more
September is the Blood Cancer Awareness Month and you have to play a role in this story! Share the word and read all you need to know by navigating here: ... Read more
Bayer HealthCare will present its latest data on copanlisib, an investigational compound for the treatment of non-Hodgkin’s lymphoma (NHL), during the 13th International Conference on Malignant Lymphoma (ICML). The conference occurs between June 17 to 20, 2015, ... Read more
Pharmacyclics, Inc. presented data on ibrutinib (IMBRUVICA), both as a single-agent and in combination with other treatments, during the 51st American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL. IMBRUVICA ... Read more
Non-invasive prenatal testing (NIPT) to look for chromosomal fetal disorders is increasingly used to test for conditions like Down’s syndrome. NIPT allows the examination of fetal DNA without any risk for both the baby ... Read more
AbbVie has recently announced recent data on its investigational hematological malignancy medicines will be presented during the 20th European Hematology Association Annual Congress (EHA), June 11 and 14, Vienna. The oral presentation will include results regarding ... Read more
